FUROSEMIDE INDUCED HYPOKALEMIA

PHARMACY

Hypokalemia is a commonly encountered electrolyte imbalance in clinical practice, affecting up to 21% of hospitalized patients. Diuretic therapy is a major contributor to the development of hypokalemia, with as many as 80% of patients on diuretics at risk of developing this condition. The prevalence of hypokalemia varies between 7% and 56%, depending on the dosage and type of diuretic used. Hypokalemia is a frequent complication associated with diuretic use, especially in populations such as the elderly, women, patients with edematous conditions, and those receiving higher doses or more potent diuretics. Preventive strategies for hypokalemia include a low-sodium diet supplemented with potassium, magnesium, and chloride, either through potassium-rich foods or potassium chloride supplements. In cases where hypokalemia persists despite these measures, the use of low doses of short-acting diuretics in managing mild to moderate hypertension is advised. In the case presented, the patient developed hypokalemia as a result of furosemide therapy, which was subsequently managed by the addition of potassium supplements.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.